190 related articles for article (PubMed ID: 37450666)
21. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
[TBL] [Abstract][Full Text] [Related]
22. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
[TBL] [Abstract][Full Text] [Related]
23. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
[TBL] [Abstract][Full Text] [Related]
24. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
[TBL] [Abstract][Full Text] [Related]
25.
Kim HI; Hong SH; Ku JM; Kim MJ; Ju SW; Chang SW; Cheon C; Ko SG
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31936835
[TBL] [Abstract][Full Text] [Related]
26. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
27. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
Aeder SE; Martin PM; Soh JW; Hussaini IM
Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
[TBL] [Abstract][Full Text] [Related]
28. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.
Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH
Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642
[TBL] [Abstract][Full Text] [Related]
29. CDKL3 Promotes Non-small Cell Lung Cancer by Suppressing Autophagy Via Activation of PI3K/Akt/mTOR Pathway.
Li R; Chai L; Lei L; Guo R; Wen X
Mol Biotechnol; 2023 Sep; 65(9):1421-1431. PubMed ID: 36630073
[TBL] [Abstract][Full Text] [Related]
30. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
32. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
33. NQO1 drives glioblastoma cell aggressiveness through EMT induction via the PI3K/Akt/mTOR/Snail pathway.
Zheng L; Yang S; Xu R; Yang Y; Quan J; Lin Z; Quan C
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594082
[TBL] [Abstract][Full Text] [Related]
34. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract][Full Text] [Related]
36. ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression.
Yang K; Luan L; Li X; Sun X; Yin J
J Neurooncol; 2022 Jan; 156(1):123-137. PubMed ID: 34797524
[TBL] [Abstract][Full Text] [Related]
37. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
38. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
39. Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.
Wang J; Liu X; Hong Y; Wang S; Chen P; Gu A; Guo X; Zhao P
J Exp Clin Cancer Res; 2017 Jul; 36(1):96. PubMed ID: 28716053
[TBL] [Abstract][Full Text] [Related]
40. Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells.
Zhu Z; Zhang P; Li N; Kiang KMY; Cheng SY; Wong VK; Leung GK
Biomed Res Int; 2019; 2019():2710693. PubMed ID: 31662972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]